Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Deferred Tax Liability (2022 - 2023)

Bicycle Therapeutics' Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $3.4 million for Q4 2023.

  • For Q4 2023, Non-Current Deferred Tax Liability fell 23.1% year-over-year to $3.4 million; the TTM value through Dec 2023 reached $3.4 million, down 23.1%, while the annual FY2023 figure was $3.4 million, 23.1% down from the prior year.
  • Non-Current Deferred Tax Liability reached $3.4 million in Q4 2023 per BCYC's latest filing, down from $4.4 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.4 million in Q4 2022 to a low of $3.4 million in Q4 2023.